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N-methylglutamine (MeGln), Leu, Arg, and two residues of Thr, which were also found in callipeltin A (1). One 
additional spin system corresponding to a 3,4-dimethylpyroglutamic acid residue was also evident in the COSY 
spectrum; starting at the NH resonance at 6 8.03 ppm leads to the subsequent cross peaks at 6 4.27 ppm (a-H), 
the CßH at 6 2.99 ppm and CyH at 6 3.54 ppm; the cross peaks CßH-CH3 at 6 0.89 ppm and CyH-CH3 at 6 1.26 
ppm were also observed in the same spectrum. 
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NOESY cross-peaks in 2 
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Table 1. 'H and 13C NMR data of callipeltin B (1) in pyr-d5 and methanol-d4 at 500 MHz. 
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4.12 overlapped 
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5.50 overlapped 
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27.5 
26.3 
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57.0 
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39.9 
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13.6 
168.8 
182.0 
Table 2. 
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and 13C NMR dab 
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1.15 overlapped 
1.33 d (6.8) 20.2 
172.6 
1.45 d (9.5) 
2.23 m 
1.05 d (6.8) 
2.66 m 
1.21 (6.5) 
57.7 
39.6 
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41.8 
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AGDHE: 4-amino-7guanidino-2,3-diiydroxyheptanoyl residue. 
TMJBTA: 3-hydroxy-2,4,6-trimethylheptanoyl residue. 
'Assigments based on 2D-COSY, 2D-HOHAHA, NOESY and HETCOR experiments.bCoupling constants are 
enclosed in parenthesis and given in Hertz. Quaternary carbons are assigned by comparison with callipeltin A (1). 
Amino acids analysis together with HPLC analysis of the acid hydrolyzate derivatized with Marfey's reagent14 
indicated the same absolute stereochemistry for the common'amino acids (L-Ala, L-NMeAla, L-Leu, L-Thr and 
D-Arg). The uncommon ß-Methoxytyrosine residue was not released intact from 2 by acid hydrolysis, just as in 
the case of the hydrolysis of callipeltin A (l), and was identified only by analysis of 'H and 13C NMR data (Table 
1). The relative stereochemistry of the 3, CdiMepyroGlu residue in 2 was suggested by NOE data which 
indicated that H a  and both the methyls were located on the same side of the molecule. The L (2s) configuration 
of both 3, CdiMepyroGlu and NMeGln residues was suggested by analogy with callipeltin A.'* The sequence of 
cyclic peptide was found to be identical to callipeltin A (1) by NOESY experiment in pyridine-ds, which gave 
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sequential informations from correlation between amide protons and a-protons of the adjacent residue via amide 
bond, as shown in 2. The ß-proton of Thr-2 resonating at low field, 6 6.01 in pyridine-d5 and 5.50 in methanol- 
d4, very close to the same signal in callipeltin A, confirmed the participation of this residue in the lactone ring 
formation with the C-terminal MeAla, whose a-proton did not give rise to cross peaks with any amide protons in 
the NOESY spectrum. Further, a NOE cross-peak between NH-Thr-2 and H a  3, 4-diMepyroGlu confirmed the 
3, 4-diMepyroGlu N-terminal to be Wed to the Thr-2 residue. Next, callipeltin B (2) was treated with sodium 
methoxide in methanol to furnish the acyclic methyl ester 4, which was generated by methanolysis of the lactone 
ring of 2. The FAB MS of 4 provided, in addition to the quasi-molecular ion MH' at mdz 1063, several fragment 
ion peaks, which were consistent with the amino acid sequence of 2 as shown in 4. 
3 
1 
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In addition to some N-terminal fragments due to the cleavage of the linkage adjacent to the amide bond and 1H 
trasfer, the spectrum showed a series of C-terminal fragments, i.e. with the charge retained on the C-terminus, 
originating by protonation of the amide followed by the cleavage of the amide peptide bond. Minor satellite 
peaks, [MH-15]+ confirmed these ions as C-terminus fragments; 925-910,824-809; 723-708; 567-55215 
Callipeltin C (3) is closely related to Callipeltin A (1). The MH’ at d z  1523 in the FAB mass spectrum, 
18 mass units higher than callipeltin A, together with ‘H and13C NMR (Table 2) spectra suggested callipeltin C 
(31 to be the acyclic callipeltin A (1). The ‘H and13C NMR spectra were very similar with those 0f callipeltin A 
except for the signals assigned to Hß and Cß of the Thr-2 residue. In 3 these signals were found shifted upfield 
to 6 4.50 and 68.3 ppm (CD30D) respectively, relative to the same signal in the spectra of 1 (& 5.60, ¿k 72.4). 
FAB mass spectrum showed identical fragmentation ion peaks observed in the spectrum of the acyclic methyl 
ester derived from callipeltin A by treatment with sodium methoxide. The N-terminus fragmentation due to the 
cleavage of the linkage adjacent to the amide bond and 1H transfer confirmed the aminoacid sequence as shown 
in 3. 
Callipeltins A-C were cytotoxic against various human carcinoma cells in vitro (Table 3) and the 
activities of 1 and 2 exceed significantly those of 3, thus suggesting the importance, of the macrocycle for the 
bioactivity. Compounds 1 and 3 also exhibited antifungal activity against Cundida albicans showing 30 mm and 
9 mm inhibition at 100 pg/disc, respectively. Whereas callipeltin A (1) showed anti-HIV activity,12 callipeltins B 
and C proved to be inactive as antiviral compounds. 
Table 3. In vitro cytotoxic activity (IC5” in pg/mI) of cdlipeltins A-Ca 
Tumor cells 1 2 3 
NSCLC-N6 <1.1 1.3 53.5 
NSCLC-N6 C15 >30 22.5 
NSCLC-N6 C92 <3.3 >30 
NSCLC-N6 C98 <3.3 <3.3 
E39 <1.1 >10 36.1 
P388 <3.3 <3.3 
M96 <3.3 <3.3 
a) NSCLC-N6 human bronchopulmonary non-small-cell-lung-carcinoma; [C 115, C92, C98 are clones of NSCLC- 
N6 cell line; they differ in chemiosensibility, having different doubling times, 91, 108 and 74 hours, respectively. 
One might consider C15 and C 92 as being well differentiated clones, whereas C98 is a less differentiated clone 
of NSCLC-N6 cell line]. E 39: human renal carcinoma; P 388: murine leukemia; M 9 6  human melanoma. Assays 
made at three diluitions 3.3 pg/ml; 10 pg/ml and 30 pg/ml 
Experimental Section 
General Information. For general details see: D’ Auria M.V. et. all6 
Isolation. Callipeltu sp. (Demospongiae, Lithistida, Corallistidae), was collected in 1992 and ‘93 in the shallow 
waters of East coast of New Caledonia. Taxonomic identification was performed by Professor Claude Lévi, 
Muséum National d’Histoire Naturelle, Paris, France, and reference specimens are on file (reference 1572) at the 
ORSTOM Centre of Noumea. Preliminary tests of bioactivity on polar extracts showed antifungal activity 
against Fiisariiim oxysporum, Helminthosporium sativum and Phytophtoru hevea, cytotoxic activity against KB 
and P388 cells (10 yg/ml, ca. 80% inhibition, in both cases) and anti-HIV activity. 
The organism were freeze-dried and the lyophilized matherial (700 g) was extracted with n-hexane and CHzClz 
in a Soxhlet apparatus, then with CH2CIZ:MeOH 8:2 (3x2 L) at room temperature. The dichloromethane- 
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methanol extract was filtered and concentrated under reduced pressure to give 10 g of a brown amorphous solid. 
The crude dichloromethane-methanol extract was injected in a DCCC apparatus in five runs (CHC13:MeOH:HzO 
7:13:8, ascending mode; fractions of 4 ml were collected). Fractions 10-12, mainly containing callipeltin C (3), 
were further purified by HPLC on a Vydac 218 TP proteine-peptide RP column (flow rate 4 mumin) with 
CH3CN:HzO (30:70) as eluent to give 70 mg of pure 3 ( t ~ 6 . 8  min). Fractions 13-17 contained callipeltin A (1) 
while fractions 18-23, mainly containing callipeltin B(2), were further purified by HPLC on a Vydac column 
(flow rate 4 mumin) with CH3CN:H20 (3268) as eluent to give 25 mg of pure 2 (t~5.2min). 
Callipeltin B (2): [a]~=+11.3" (c 0.0057 M, MeOH); UV (MeOH) Lax 230 (~=7023), 274 (&=1300); IR 
(KBr) 3335,1740, 1660,1520 cm";'H and I3C NMR in the Table 1; FAJ3MS mdz 1031, MH' 
Callipeltin C (3): [a]~=-15.3' (c 0.0053 M, MeOH); UV (MeOH) han 230 (&=6890), 274 (&=1320); IR 
(KBr) 3330, 1740, 1660, 1520 cm*';'H and I3C NMR in the Table 2; FABMS in/' 1523, MH' 
Determination of Amino Acid Absolute Configuration. (a) Hydrolysis of callipeltins. 100 pg of 
caVipeltin B (1) and callipeltin C (3)were dissolved respectively in 0.5 ml of 6 N, HC1 in two evacuated glass 
tubes and heated at 110 "C for 16 h. The residues were taken to dryness. (b) HPLC Analysis of the Marfey's 
de ri vat ive^.'^ To a 10% acetone solution (50 pl) of l-fluoro-2,4-dinitrophenyl-5-alanine amide (L-FDAA) and 
IN N a c o 3  (40 pl) were added 100 pg of the peptide acid hydrolysate of callipeltin B and the mixture wastkept 
at 50 "C for 1 h. After cooling to room temperature 2N HC1 (40 p1) was added and the resulting solution was 
taken to dryness and then dissolved in 500 pl of DMSO. A 5 p1 aliquot of the FDAA derivatives was analyzed by 
reversed-phase HPLC. A linear gradient from triethylammonium phosphate (50 nM, pH 3.0)NeCN 90% to 
triethylammonium phosphate (50 nM, pH 3.0)/MeCN 50% over 45 min (flow rate 2 mumin) was used to 
separate the FDAA derivatives which were detected by uv at 340 Amino acids were derivatized as 
described above. The peaks were identified by Co-injection with a DL-mixture of standard amino acids. 
Retention times (min) are given in parentheses. LThr  and D-Arg (18.1), L-MeAla (21.6), L-Leu (37.6). The 
same procedures were apllied to 100 pg of callipeltin C. Retention times (min): L-Thr and D-Arg (18. l), LAla 
(21.6), L-MeAla (28.3), L-Leu (37.6). 
Methanolysis of Callipeltin B (1) Giving the Opened Methyl Ester (4). A solution of 1 mg of 
callipeltin B (1) was treated with 1.1 mg of NaOMe in dry methanol (0.2 ml) at room temperature for 2 h. The 
reaction mixture was neutralized with 0.1N HCl, poured into ice-water and then extracted with a-BuOH. The n- 
BuOH phase was evaporated under reduced pressure and the crude product (0.8 mg) directly subjected to 
FABMS analysis. 
Determination of biological activity. NSCLC-N6-L16, C15, C92, C98, E39, M96, cells were 
mainteined in a suspension culture of RPMI supplemented with 5% calf serum containing 1% of glutamine 
solution at 200 mM and 1% of a penicillin-streptomycin mixture (10000 UVml). A 50 pl aliquot of each cell 
culture [P388 cells (5x103)] was mixed with 50 p1 aliquot of serial dilution (3.3 pg/ml; 10 pg/ml and 30 yglml) 
of compounds and the mixture was incubated in a microtited well plate (96-well Falcon 3072) for 72 h at 37 "C 
in a humified incubator comtaining 5% COz in air.Cell proliferation was estimated by a colorimetric test: 10 pl of 
MTT was added. After 4 h the dark blu cristals, formed in mitochondria of living cells during the reduction of 
MTT, were solubilized with 100 p1 of isopropanoic acid. Microplates were read by ELISA using a multiskar 
Titertek multiscan MK2 with a 570 nm filter. 
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